Overview
Dr. Romine was drawn to the field of medical oncology because of the close and privileged relationship oncologists are able to develop with their patients and families. She loves the opportunity to combine the latest research with personalized care in order to best meet each patients' unique goals of care. Cancer care takes a huge amount of support, and she relishes practicing in an environment with a strong multidisciplinary team and excellent support staff to help support patients and their families in providing the best possible care.
Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Salivary Gland Tumors, and Breast Cancer.
Her clinical research consists of co-authoring 13 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- EPO
- HMO
- HMO
- MANAGED MEDICAID PLAN
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
Accepted plan types not found. Please verify directly with the provider.
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- EPO
- PPO
- EPO
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Additional Areas of Focus
Dr. Romine has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Rachel Loschiavo PA-C
Mazyar Shadman is a Hematologist in Seattle, Washington. Dr. Shadman is highly rated in 23 conditions, according to our data. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Small Lymphocytic Lymphoma (SLL), Non-Hodgkin Lymphoma, and Bone Marrow Transplant.
The Association Of University Physicians
Arjun Law is a Hematologist Oncology specialist and an Oncologist in Seattle, Washington. Dr. Law is highly rated in 5 conditions, according to our data. His top areas of expertise are Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Acute Myeloid Leukemia (AML), Leukemia, and Bone Marrow Transplant.
Rachel Loschiavo PA-C
Andrei Shustov is a Hematologist in Seattle, Washington. Dr. Shustov is highly rated in 24 conditions, according to our data. His top areas of expertise are Peripheral T-Cell Lymphoma, T-Cell Lymphoma, Anaplastic Large Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.
Frequently Asked Questions about Dr. Perrin E. Romine
How do I make an appointment with Dr. Perrin E. Romine?
You can book an appointment with Dr. Perrin E. Romine by calling their office at 425-673-8300. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Perrin E. Romine a top-rated expert for Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Perrin E. Romine is classified as an Experienced expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Perrin E. Romine specialize in?
While Dr. Perrin E. Romine is a Hematology Oncology, they have specific expertise in Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Salivary Gland Tumors. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology Oncology.
Does Dr. Perrin E. Romine participate in research or clinical trials?
Yes. Dr. Perrin E. Romine has published 13 articles and abstracts on conditions like Lung Cancer. You can view a list of Dr. Perrin E. Romine's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Perrin E. Romine accept my insurance?
Dr. Perrin E. Romine accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 425-673-8300 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Breast CancerDr. Romine isExperienced. Learn about Breast Cancer.
- Lung CancerDr. Romine isExperienced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Romine isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Salivary Gland TumorsDr. Romine isExperienced. Learn about Salivary Gland Tumors.